To the Editor: In China, the pathological types such as mild lesion nephrosis (MLN), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and IgA nephropathy (IgAN) are presented as common types in patients with chronic kidney disease (CKD).\[[@ref1]\] For identifying the special CKD pathological types, ultrasound-guided percutaneous renal biopsy is an important diagnostic tool for nephrologists. Clinically, the postbiopsy complications, such as gross hematuria caused by renal hemorrhage, low back pain or abdominal pain caused by perirenal hematoma, or mild fever, will occur in some patients. Further, some CKD patients are unfeasible to perform renal biopsy due to clinical contraindications. Here, a systematic method to evaluate or predict CKD pathological types by the statistical probabilities of clinical indices is proposed. The method is based on frequency differences regarding basic properties, clinical characteristics, and laboratory results of CKD patients. This study aimed to establish an alternative method for identifying CKD pathological types from a nontraumatic statistical perspective.

Data of 520 CKD patients from electronic medical databases of a tertiary referral hospital between July 2014 and July 2016 were collected retrospectively to perform the statistical prediction; those were diagnosed pathologically including MLN (*n* = 120), FSGS (*n* = 122), MN (*n* = 141), and IgAN (*n* = 137). Further, the indices of CKD cases were classified as basic characteristics, medical history, clinical signs, and laboratory results according to the corresponding standards, which were included in the list of predictive variables; detailed data were shown in Supplementary Materials.

###### 

Classification of clinical indices in CKD patients

  -------------------------------------------------------------------------------------------------------
  Basic characteristics
   1: Gender (female; male)
   2: Marriage (unmarried; married; divorced/widowed)
   3: Occupation (farmers/unemployed; worker/employee; freelance worker; student; health-care workers)
  Epidemiological history
   4: Duration (≤1 Y; \>1 Y; ≤3 Y; \>3 Y); D, Duration; Y, years
   5: Frequency of admission (1; ≥2)
   6: First-onset age (\<20 Y; 20--40 Y; \>40 Y); FOA
   7: First drugs use before admission (antibiotics/antiviral drugs; G+/ISD; TCM/PCM; nonspecial drugs)
   8: CKD-related inducements (CKD-related inducements 0\~10); CKD-RI
  Clinical signs
   9: Edema signs (none; edema of face/lower extremity); Edema-F/L
   10: Hematuria (none; \<2 Y; ≥2 Y); hematuria ≥2 Y
   11: Proteinuria (none; \<2 Y; ≥2 Y); proteinuria ≥2 Y
   12: Blood pressure (normal; high blood pressure); BP
  Laboratory results
   13: Blood lipid (normality; high); BL
   14: Blood glucose (normality; elevation); B-Glu
   15: Alanine aminotransferase (normality; elevation); ALT
   16: Blood urea nitrogen (normality; increase); BUN
   17: Serum creatinine (normality; increase); Cr
   18: Blood uric acid (normality; elevation); BUA-elevation
   19: Blood calcium (normality; lower); Ca
   20: Blood phosphorus content (normality; lower; high); P
   21: Blood Kalium (normality; lower; increase); K
   22: Hemoglobin (normality; reduce); Hb
   23: Platelet count (normality; reduce; high)
   24: Blood α1-globulin (normality; increase; lower); α1Glb
   25: Blood α2-globulin (normality; decrease; elevation); α2Glb
   26: Albumin (normality; lower); Alb
   27: Serum ferrum (normality; increase; lower); Fe
   28: Serum complement 3/4 (normality; lower; increase); C3/C4
   29: Thrombin/activated partial thromboplastin time (normality; lengthen; shorten); T/APTT
   30: D-dimer (normality; elevation); High-DD
   31: Erythrocyte sedimentation rate (normality; quicken); ESR
   32: Parathyroid hormone (normality; increase; reduce); PTH
   33: Urine bilirubin (negative; positive); U-Bil
   34: Urine Bence-Jones protein (normality; lower; elevation); UBJP-E (elevation)
   35: Immunoglobulin E (normality; increase); IgE
   36: Immunoglobulin G (normality; higher; lower); IgG-lower
   37: Immunoglobulin A (normality; increase; decrease); IgA
   38: Urine tube/pathological tube (normality; increase); Tube-I/PI
   39: Urine leukocyte number (normality; increase); Urine leukocyte I (increase)
   40: Urine epithelium number (normality; increase); Urine epithelium I (increase)
  -------------------------------------------------------------------------------------------------------

Number, indices (classification) and abbreviation are shown in order. G+/ISD: Glucocorticoid +/immunosuppressive drug; TCM/PCM: Traditional Chinese medicine/proprietary Chinese medicine; FOA: First-onset age; Free-worker: The type of occupation is free-worker; CKD-RI 0: CKD of unknown reasons (CKD-UR); CKD-RI 1: Cold/tonsillitis/upper respiratory infection (Cold/T/UPI); CKD-RI 2: Pregnancy/cesarean delivery/anemia (pregnancy/C/A); CKD-RI 3: Hepatitis A or hepatitis B or tuberculosis (hepatitis A/B/TB); CKD-RI 4: Stones/cyst/trauma of kidneys (kidney-stones/C/T); CKD-RI 5: Infection of urinary tract/bowel/lung (U/B/L-infection); CKD-RI 6: Hypertension-related kidney injury (Hyper-KI); CKD-RI 7: Thyroid disease-related kidney injury (thyroid-KI); CKD-RI 8: Rash/ringworm/allergic disease-related kidney injury (Rash/R/A-KI); CKD-RI 9: Acute kidney injury/acute glomerulonephritis (AKI/AGN); CKD-RI 10: Tired/chronic diseases/appendicitis operation later (Tired/C/A).

###### 

Indices for prediction of CKD pathological type

  Types                                                                              Positive indices (P1, %)   Negative indices (P2, %)                                          
  ---------------------------------------------------------------------------------- -------------------------- ----------------------------------------- ----------------------- ----------------------
  MLN (*n* = 120)                                                                    Male (81.7)                D ≤1Y (65.8)                              Proteinuria ≥2Y (1.7)   Hematuria ≥2Y (1.7)
  Proteinuria \<2Y (80.8)                                                            High-BL (69.2)             UBJP-E (25.0)                             CKD-RI 4 (0.8)          
  IgG-lower (42.5)                                                                   Edema-F/L (59.2)           High-BP (20.8)                            P-lower (5.0)           
  FOA.20-40Y (45.0)                                                                  Alb-lower (51.7)           High-DD (33.3)                            ESR-quicken (22.5)      
  Hematuria\<2Y (64.2)                                                               Ca-lower (49.2)            Hb-R (6.7) Female (18.3)                  FOA.\<20Y (25.8)        
  FSGS (*n* = 122)                                                                   FOA.20-40Y (52.5)          D ≤1Y (62.3)                              Proteinuria ≥2Y (9.0)   IgG-lower (27.0)
  Hematuria \<2Y (64.8)                                                              Proteinuria \<2Y (78.7)    Fe-lower (8.2) High-DD (30.3)             CKD-RI 5/7/8 (1.6)      
  Edema-F/L (52.5)                                                                   UBJP-E (60.8)              P-lower (6.6) ESR-quicken (32)            K-lower (9.8)           
  Ca-lower: (47.5)                                                                   High-BL: (63.9)            FOA.\<20Y (10.7) α2Glb-elevation (17.2)   α1Glb-lower (18.9)      
  CKD-RI 0 (36.1)                                                                    Female (53.3)              Tube-I/PI (24.6) HB-R (13.1)              Hematuria ≥2Y (8.2)     
  MN (*n* = 141)                                                                     FOA.\>40Y (60.3)           D ≤1Y (74.5)                              α1Glb lower (7.1)       No-proteinuria (2.1)
  Hematuria \<2Y (66.7)                                                              Proteinuria \<2Y (87.9)    CKD-RI 7/8 (0.7)                          Hematuria ≥2Y (0.7)     
  Alb-Lower (83.0)                                                                   IgG-lower (49.6)           ESR-quicken (47.5)                        D \>3Y (7.8)            
  High-DD (58.2)                                                                     Tube-I/PI (54.6)           FOA \<20Y (7.1)                           P-higher (19.1)         
  CKD-RI 0 (38.1)                                                                    Edema-F/L (91.5)           Hb-R (18.4)                               K-lower (15.6)          
  High-BL (85.1)                                                                     Ca-lower (66.7)            Proteinuria ≥2Y (9.9)                     Fe-Lower (12.8)         
  UBJP-E (66.7)                                                                                                                                                                   
  IgAN (*n* = 137)                                                                   Female (59.1)              FOA.20-40Y (70.8)                         Hematuria ≥2Y (10.9)    ESR-quicken (9.5)
  Hematuria \<2Y (72.3)                                                              Proteinuria \<2Y (70.1)    High-BP (31.4)                            Edema-F/L (30.7)        
  Proteinuria ≥2Y (10.9)                                                             α2Glb elevation (4.4)                                                                        
  D ≤1Y (67.9)                                                                       CKD-RI 1 (38.0)            High-DD (14.6)                            K-lower (11.7)          
                                                                                                                Hb-R (8.8)                                P-lower (6.6)           
  Prediction of MLN or FSGS or MN or IgAN: ∑ (PP ± SE~P1~) - ∑ (NP ± SE~P2~) + 50%                                                                                                

Prediction probability of CKD pathological types was evaluated by calculating the difference of total positive indices frequency minus total negative indices frequency, the formula is expressed as "ΣPP ± \[![](CMJ-131-2741-g001.jpg) × (1 − ![](CMJ-131-2741-g001.jpg))/n\]^1/2^} − {ΣNP ± \[![](CMJ-131-2741-g002.jpg) × (1 − ![](CMJ-131-2741-g002.jpg))/n\]^1/2^} + 50%." Standard error: \[![](CMJ-131-2741-g001.jpg) × (1 − ![](CMJ-131-2741-g001.jpg))/n\]^1/2^ or \[![](CMJ-131-2741-g002.jpg) × (1 − ![](CMJ-131-2741-g002.jpg))/n\]^1/2^ was abbreviated as SEP1, SEP2, respectively. SEP1 or SEP2 was calculated by the mean value of PP or NP in one CKD patient, respectively. Edema-F/L: Edema of face/lower extremity; High-DD: D-dimer elevation; Tube-I/PI: Urine tube/pathological tube increase; UBJP-E: Urine Bence-Jones protein elevation; Hb-R: Hemoglobin reduce; ESR-quicken: Erythrocyte sedimentation rate quicken; High-BP: High blood pressure; High-BL: High blood lipid; P-lower: Lower content of blood phosphorus; Alb-lower: Lower albumin content; Ca-lower: Blood calcium lower; K-lower: Blood Kalium lower; Fe-Lower: Serum ferrum lower.

###### 

Calculation of prediction probability in one CKD patient

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Predictive indices in CKD patients            Judgments of induces                                                                                        MLN\            FSGS\           MN\             IgAN\
                                                                                                                                                            PP (+)/NP (-)   PP (+)/NP (-)   PP (+)/NP (-)   PP (+)/NP (-)
  --------------------------------------------- ----------------------------------------------------------------------------------------------------------- --------------- --------------- --------------- ---------------
  D ≤1 y                                        Yes; no                                                                                                     0.328           0.293           0.415           0.349

  D \>3 y                                       Yes; no                                                                                                                                     −0.252          

  Hematuria \<2 y                               Yes; no                                                                                                     0.312           0.318           0.334           0.393

  Ca-lower                                      Yes; no                                                                                                     0.159           0.142           0.334           

  Proteinuria \<2 y                             Yes; no                                                                                                     0.478           0.457           0.549           0.371

  High-DD                                       Yes; no                                                                                                     −0.167          −0.197          0.082           −0.354

  Edema-F/L                                     Yes; no                                                                                                     0.092                           0.415           −0.193

  Alb-lower                                     Yes; no                                                                                                     0.017                           0.33            

  IgG-lower                                     Yes; no                                                                                                     0.092                           0.166           

  ESR-quicken                                   Yes; no                                                                                                     −0.275          −0.18                           −0.405

  UBJP-E                                        Yes; no                                                                                                     −0.083          0.275           0.334           

  Tube-I/PI                                     Yes; no                                                                                                                     −0.254          0.046           −0.186

  FOA.20-40 y                                   Yes; no                                                                                                     0.117           0.192                           0.378

  FOA.\>40 y                                    Yes; no                                                                                                                                     0.270           −0.202

  FOA.\<20 y                                    Yes; no                                                                                                     −0.075          −0.226          −0.262          −0.172

  P-lower                                       Yes; no                                                                                                     −0.28           −0.264          −0.191          −0.264

  High-P                                        Yes; no                                                                                                     −0.033                          −0.139          

  HB-R                                          Yes; no                                                                                                     −0.433          −0.369          −0.316          −0.412

  High-BL                                       Yes; no                                                                                                     0.192           0.139           0.351           

  High-BP                                       Yes; no                                                                                                     −0.292                                          −0.186

  Low-K                                         Yes; no                                                                                                     −0.166          −0.232          −0.177          −0.213

  CKD-RI 0                                      Yes; no                                                                                                                     0.111           0.131           

  CKD-RI 1                                      Yes; no                                                                                                     −0.03                           −0.128          0.13

  Hematuria ≥2 y                                Yes; no                                                                                                     −0.316          −0.251          −0.326          −0.224

  Fe-lower                                      Yes; no                                                                                                     −0.233          −0.251          −0.205          −0.224

  Proteinuria ≥2 y                              Yes; no                                                                                                     −0.316          −0.243          −0.234          −0.213

  No-proteinuria                                Yes; no                                                                                                                                     −0.312          −0.151

  Female                                        Yes; no                                                                                                     −0.317          0.033                           0.091

  Male                                          Yes; no                                                                                                     0.317                                           

  α1Glb lower                                   Yes; no                                                                                                     −0.158          −0.144          −0.262          −0.187

  α2Glb elevation                               Yes; no                                                                                                     −0.15           −0.161                          −0.289

  Definition-PP/NP                              PP was defined as "P1-0.5" or "P1-0.33" or "P1-0.25" NP was defined as "0.5-P2" or "0.33-P2" or "0.25-P2"                                                   

  Range of prediction probability in patients   {∑ (PP + SE~P1~) − ∑ (NP + SE~P2~) + 50%} \~ {∑ (PP−SE~P1~) − ∑ (NP−SE~P2~) + 50%}                                                                          
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

When predictive indices in CKD patients were judged as "yes," the values of NP or PP in each CKD pathological type was calculated and summed, respectively. If "No," the corresponding values in CKD pathological types are invalid. Further, SEP1 or SEP2 was calculated by the formula of standard error referred to the mean level of NP or PP in each CKD pathological type. As a result, the probability ranges of each pathological type can be obtained in patients.

###### 

Application of differential diagnosis in one CKD patient

  Propensity indices of differential diagnosis   Yes or no of induces   Evaluation of ∑OR1-∑OR2 by logistic models   
  ---------------------------------------------- ---------------------- -------------------------------------------- ---------------
  Proteinuria≥2Y                                 Yes; no                11.819                                       \>0
  UBJP-E                                         Yes; no                5.722                                        
  TCM/PCM                                        Yes; no                3.316                                        
  FOA\>40 Y                                      Yes; no                2.780                                        
  High-BP                                        Yes; no                2.284                                        
                                                                                                                     
  **MLN**                                                               **OR2 values**                               **∑OR1-∑OR2**
                                                                                                                     
  Male                                           Yes; no                6.211                                        \<0
  IgG-lower                                      Yes; no                3.425                                        
  Tube-I/PI                                      Yes; no                1.969                                        
                                                                                                                     
  **FSGS**                                       **Judgment**           **OR1 values**                               **∑OR1-∑OR2**
                                                                                                                     
  ESR-quicken                                    Yes; no                3.651                                        \>0
  α2Glb lower                                    Yes; no                2.999                                        
  FOA\>40 Y                                      Yes; no                2.505                                        
  High-BL                                        Yes; no                2.217                                        
                                                                                                                     
  **IgAN**                                                              **OR2 values**                               **∑OR1-∑OR2**
                                                                                                                     
  Cold/T/UPI                                     Yes; no                5.848                                        \<0
  U/B/L-infection                                Yes; no                4.808                                        
                                                                                                                     
  **IgAN**                                       **Judgment**           **OR1 values**                               **∑OR1-∑OR2**
                                                                                                                     
  Proteinuria ≥2 Y                               Yes; no                25.986                                       \>0
  High-BP                                        Yes; no                3.555                                        
  FOA 20-40 Y                                    Yes; no                3.089                                        
                                                                                                                     
  **MLN**                                                               **OR2 values**                               **∑OR1-∑OR2**
                                                                                                                     
  Male                                           Yes; no                13.889                                       \<0
  ESR-quicken                                    Yes; no                3.876                                        
  High-BL                                        Yes; no                3.861                                        
  ALB-lower                                      Yes; no                3.378                                        
                                                                                                                     
  **IgAN**                                       **Judgment**           **OR1 values**                               **∑OR1-∑OR2**
                                                                                                                     
  AKI/AGN                                        Yes; no                19.244                                       \>0
  FOA \<20 Y                                     Yes; no                8.79                                         
  Hepatitis A/B/TB                               Yes; no                7.013                                        
  Hyper-RD                                       Yes; no                5.364                                        
  Cold/T/UPI                                     Yes; no                2.885                                        
                                                                                                                     
  **MN**                                                                **OR2 values**                               **∑OR1-∑OR2**
                                                                                                                     
  Edema-F/L                                      Yes; no                10.526                                       \<0
  High-BL                                        Yes; no                6.25                                         
  ESR-quicken                                    Yes; no                5.587                                        
                                                                                                                     
  **MN**                                         **Judgment**           **OR1 values**                               **∑OR1-∑OR2**
                                                                                                                     
  Proteinuria ≥2 Y                               Yes; no                12.284                                       \>0
  UBJP-E                                         Yes; no                4.829                                        
  TCM/PCM                                        Yes; no                4.742                                        
  Edema-F/L                                      Yes; no                3.045                                        
  High-BP                                        Yes; no                2.626                                        
                                                                                                                     
  **MLN**                                                               **OR2 values**                               **∑OR1-∑OR2**
                                                                                                                     
  Student                                        Yes; no                5.988                                        \<0
  Male                                           Yes; no                3.534                                        
                                                                                                                     
  **MN**                                         **Judgment**           **OR1 values**                               **∑OR1-∑OR2**
                                                                                                                     
  Edema-F/L                                      Yes; no                7.018                                        \>0
  P-lower                                        Yes; no                3.889                                        
  Tube-I/PI                                      Yes; no                3.309                                        
  ALB-lower                                      Yes; no                2.554                                        
  High-BL                                        Yes; no                2.436                                        
                                                                                                                     
  **FSGS**                                                              **OR2 values**                               **∑OR1-∑OR2**
                                                                                                                     
  Free-worker                                    Yes; no                3.876                                        \<0
  Ca-lower                                       Yes; no                1.957                                        

OR value, value of odds ratio by the analysis of logistic regression model; when the indices of CKD patients were judged as "yes," the values of OR in each CKD pathological type were calculated and summed, respectively; If "No," the values of OR in CKD pathological types are invalid; the judgment of CKD pathological types indicates the group with the larger value of ∑OR, ∑ is a symbol of summation in mathematics.

###### 

Assessment of goodness of fit in logistic models

  Logistic models   Accuracy rate (%)   ROC area under the curve   Asymptotic 95%*CI*   H-L test *P*
  ----------------- ------------------- -------------------------- -------------------- --------------
  FSGS－MLN         78.5                0.858\*                    0.812--0.904         0.152
  FSGS－IgAN        70.3                0.808\*                    0.757--0.860         0.470
  IgAN－MLN         78.2                0.863\*                    0.820--0.907         0.613
  IgAN－MN          83.4                0.929\*                    0.900--0.959         0.578
  MN－MLN           78.9                0.871\*                    0.828--0.914         0.803
  MN－FSGS          75.7                0.829\*                    0.780--0.878         0.905

\*Asymptotic *P*\<0.01. H-L test: Hosmer--Lemeshow fit goodness test; *P* value of H-L test \>0.05 indicates that logistic models are the good and fit for differential diagnosis of CKD pathological types. ROC: Receiver operating characteristic; *CI*: Confidence interval.

###### 

Theory of bi-directional probability for predicting CKD pathological types. CKD: Chronic kidney disease.

###### 

Click here for additional data file.

###### 

ROC curve of cross comparison in logistic models. (a) ROC area under the curve of distinguishing FSGS versus MLN. (b) ROC area under the curve of distinguishing FSGS versus IgAN. (c) ROC area under the curve of distinguishing IgAN versus MLN. (d) ROC area under the curve of distinguishing IgAN versus MN. (e) ROC area under the curve of distinguishing MN versus MLN. (f) ROC area under the curve of distinguishing MN versus FSGS. ROC: Receiver operating characteristic curve; AR: Accuracy rate (%); ROC-A: ROC area under the curve.

###### 

Click here for additional data file.

In accordance with the principle of bi-directional accumulation dichotomy proposed by Yang *et al*.,\[[@ref2]\] The bi-directional probability in each patient can be calculated. Firstly, based on the assumption of random event in CKD, we define 50% as the baseline probability of one CKD pathological type. Further, excess probabilities were calculated by the frequency of clinical indices occurring in each CKD pathological type, which is defined as positive probability (PP) or negative probability (NP). Consequently, the prediction probabilities for one special CKD pathological type were calculated by the following method "∑PP − ∑NP + 50%." Also, the sampling error of PP or NP was estimated by their mean levels in CKD patients (![](CMJ-131-2741-g001.jpg) or ![](CMJ-131-2741-g002.jpg)), respectively. The final calculation formula of bi-directional accumulation probability model of predicting CKD pathological types in the present study is expressed as "{ΣPP ± \[![](CMJ-131-2741-g001.jpg) × (1−![](CMJ-131-2741-g001.jpg))/n\]^1/2^} − {ΣNP ± \[![](CMJ-131-2741-g002.jpg) × (1−![](CMJ-131-2741-g002.jpg))/n\]^1/2^} + 50%."

All 520 cases were less than or equal to CKD Stage 4 according to the Kidney Disease: Improving Global Outcomes Guidelines (2012). In addition, MLN group showed a higher proportion of male patients, while IgAN group showed a lower proportion of male patients. The differences of average duration and serum creatinine among four groups were not significant (*P* \> 0.05). Then, NP or PP of four CKD pathological types was calculated according to the above formula, indicating the tendency of occurring one special pathological type, respectively. Further, in case that similar prediction probabilities occur in two or more than two CKD pathological types, the strategy of differential diagnosis needs to be performed by logistic regression analysis to distinguish between two CKD pathological types. Here, six pairs of logistic differential diagnosis models between each two CKD pathological types were established, and the indices for distinguishing special CKD pathological type were evaluated by value of odds ratio (*OR*) or the repetition times in order. The higher *OR* values or the more repetition times of the indices suggest an increased predictive probability of the corresponding pathological type occurring; detailed data are shown in [Figure 1](#F1){ref-type="fig"} and Supplementary Materials.

![Prediction indices of different pathological types in logistic models. The indicated indices of four CKD pathological types were proposed, and the value of *OR* or the mean *OR* value calculated by the repeatable indices was presented in the corresponding brackets. \*The index was repeated twice in models; ^†^The index was repeated thrice in models. CKD: Chronic kidney disease; *OR*: Odds ratio; Y: Year; Alb: Albumin; P: Phosphorus; Ca: Calcium; UBJP-E: Urine Bence-Jones Protein elevation; TCM/PCM: Traditional Chinese Medicine/Proprietary Chinese Medicine using; FOA: First onset age; BP: Blood pressure; ESR: Erythrocyte sedimentation rate; Glb: Globulin; BL: Blood lipid; Cold/T/UPI: Cold/tonsillitis/upper respiratory infection; U/B/L-infection: Infection of urinary tract/bowel/lung; AKI/AGN: Acute kidney injury/acute glomerulonephritis; hepatitis A/B/TB: Hepatitis A or hepatitis B or tuberculosis; Hyper-KI: Hypertension-related kidney injury; Edema-F/L: Edema of face/lower extremity; Tube-I/PI: Urine tube/pathological tube increase.](CMJ-131-2741-g003){#F1}

In clinical, it is well known that choosing the best treatment strategy for G1--G4 CKD patients depends on the result of CKD pathological diagnosis by renal biopsy and histopathological observation to a large extent. Renal biopsy belongs to a traumatic pathological diagnosis, which can lead to many complications such as renal hemorrhage, perirenal hematoma, mild fever, and gross or microscopic hematuria. In addition, some medical conditions such as coagulation dysfunction or infection make the operation of renal biopsy unfeasible. Some patients are also not willing to accept renal biopsy with surgery. As a result, it is difficult to choose one optimal treatment protocol for CKD patients in case of unknown pathological type. For example, the dosages and treatment cycles of hormones or immunosuppressive agents will be faced a puzzle due to each treatment strategy corresponds to each pathological type. In case of the judgment of the pathological type goes wrong, for example, FSGS is judged incorrectly to be IgAN, the inappropriate treatment in the patients will lead to an increased risk of delayed treatment efficacy or side effects of drugs. So, the statistical prediction of the CKD pathological type becomes valuable for providing a reference of choosing the appropriate treatment strategy in patients. Here, pathological prediction is evaluated by a probability strategy based on the theory of bi-directional probability in CKD patients, and the data are obtained from medical records including the patients' attributes, symptoms, signs and laboratory results.

In this study, statistical analysis was performed to evaluate the difference of the frequency distribution of clinical indices in different CKD pathological types. Then, a method of bi-directional probability (positive or negative) was applied for statistical prediction of the special CKD pathological types. Furthermore, to distinguish the similar probabilities among CKD pathologic types, the method of logistic regression was used, and the cumulative *OR* values of tendency indices in six pairs of logistic models were analyzed for discriminating the special CKD pathologic type, providing a reference for the accurate prediction of the pathologic type. In conclusions, this prediction method for the noninvasive pathological diagnosis of CKD pathological types based on a statistical perspective is feasible, providing a reference for choosing the optimal treatment strategy for CKD patients in a clinical setting.

Summarily, the present study indicated that statistical prediction of CKD pathological types can be achieved by the present mode of bi-directional probability and logistic regression, expecting to provide an auxiliary advice by the present method due to the unfeasible conditions in renal biopsy. Of course, there are some shortcomings such as the limited sample size and the limited scope of pathological classification. Furthermore, the more secondary glomerular disease and the coexistence of multiple pathological types should also be explored for the mode of prediction or differential diagnosis in future studies.

*Supplementary information is linked to the online version of the paper on the Chinese Medical Journal website*.
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